{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:06:30Z","timestamp":1793995590610,"version":"4.8.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,8]],"date-time":"2025-05-08T00:00:00Z","timestamp":1746662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009108","name":"Shandong University","doi-asserted-by":"publisher","award":["KYZK2024Q32"],"award-info":[{"award-number":["KYZK2024Q32"]}],"id":[{"id":"10.13039\/100009108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404721"],"award-info":[{"award-number":["82404721"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82474217"],"award-info":[{"award-number":["82474217"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QH063"],"award-info":[{"award-number":["ZR2024QH063"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015507","name":"Shandong First Medical University","doi-asserted-by":"publisher","award":["2019LJ003"],"award-info":[{"award-number":["2019LJ003"]}],"id":[{"id":"10.13039\/501100015507","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016697","name":"Youth Innovation Technology Project of Higher School in Shandong Province","doi-asserted-by":"publisher","award":["2024KJJ032"],"award-info":[{"award-number":["2024KJJ032"]}],"id":[{"id":"10.13039\/100016697","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Advanced Research"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jare.2025.05.014","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T19:23:17Z","timestamp":1746818597000},"page":"759-773","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease"],"prefix":"10.1016","volume":"80","author":[{"given":"Songsong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Rong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenshen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwen","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jare.2025.05.014_b0005","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.apsb.2022.10.003","article-title":"Synergistic activation of AMPK by AdipoR1\/2 agonist and inhibitor of EDPs-EBP interaction recover NAFLD through enhancing mitochondrial function in mice","volume":"13","author":"Song","year":"2023","journal-title":"Acta Pharm SinB"},{"key":"10.1016\/j.jare.2025.05.014_b0010","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1016\/j.apsb.2021.03.018","article-title":"Integrative lipidomic and transcriptomic study unravels the therapeutic effects of saikosaponins A and D on non-alcoholic fatty liver disease","volume":"11","author":"Li","year":"2021","journal-title":"Acta Pharm SinB"},{"key":"10.1016\/j.jare.2025.05.014_b0015","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"issue":"2019","key":"10.1016\/j.jare.2025.05.014_b0020","first-page":"1119","article-title":"to 2018: A Systematic Review and Meta-Analysis","volume":"70","author":"Zhou","year":"2008","journal-title":"Hepatology7"},{"key":"10.1016\/j.jare.2025.05.014_b0025","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.1002\/efd2.118","article-title":"Zhenjiang aromatic vinegar prevents the alcohol liver disease in mice via autophagy","volume":"4","author":"Zhao","year":"2023","journal-title":"eFood"},{"key":"10.1016\/j.jare.2025.05.014_b0030","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2025.05.014_b0035","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.1111\/bph.15159","article-title":"Sirtuin 3-mediated deacetylation of acyl-CoA synthetase family member 3 by protocatechuic acid attenuates non-alcoholic fatty liver disease","volume":"177","author":"Sun","year":"2020","journal-title":"Brit J Pharmacol"},{"key":"10.1016\/j.jare.2025.05.014_b0040","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1002\/hep.30097","article-title":"Acetyl-CoA carboxylase inhibition reverses NAFLD and hepatic insulin resistance but promotes hypertriglyceridemia in rodents","volume":"68","author":"Goedeke","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2025.05.014_b0045","doi-asserted-by":"crossref","first-page":"729","DOI":"10.21037\/atm-20-4354","article-title":"Non-alcoholic fatty liver disease (NAFLD)\/non-alcoholic steatohepatitis (NASH)-related liver fibrosis: mechanisms, treatment and prevention","volume":"9","author":"Tacke","year":"2021","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jare.2025.05.014_b0050","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"The Lancet"},{"key":"10.1016\/j.jare.2025.05.014_b0055","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1007\/s11883-015-0500-2","article-title":"FXR agonists as therapeutic agents for non-alcoholic fatty liver disease","volume":"17","author":"Carr","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jare.2025.05.014_b0060","doi-asserted-by":"crossref","first-page":"17545","DOI":"10.1021\/acs.jmedchem.1c01017","article-title":"Recent advances in the medicinal chemistry of farnesoid X receptor","volume":"64","author":"Fang","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.jare.2025.05.014_b0065","first-page":"1","article-title":"Nonalcoholic fatty liver disease: pathogenesis and treatment in traditional chinese medicine and western medicine","author":"Shi","year":"2020","journal-title":"Evid-Based Compl Alt"},{"key":"10.1016\/j.jare.2025.05.014_b0070","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.apsb.2022.05.001","article-title":"Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge","volume":"12","author":"Ji","year":"2022","journal-title":"Acta Pharm Sin1"},{"key":"10.1016\/j.jare.2025.05.014_b0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.53388\/TMR20220219002","article-title":"Advances in traditional Chinese medicine for liver disease therapy in 2021","volume":"7","author":"Liao","year":"2022","journal-title":"Tradit Med Res"},{"key":"10.1016\/j.jare.2025.05.014_b0080","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.771459","article-title":"The potential application of chinese medicine in liver diseases: a new opportunity","volume":"12","author":"Fu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jare.2025.05.014_b0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106925","article-title":"Natural products in non-alcoholic fatty liver disease (NAFLD): Novel lead discovery for drug development","volume":"196","author":"Wang","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jare.2025.05.014_b0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173976","article-title":"Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease","volume":"898","author":"Zhou","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jare.2025.05.014_b0095","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jare.2025.05.014_b0100","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.drudis.2006.11.008","article-title":"Multi-target therapeutics: when the whole is greater than the sum of the parts","volume":"12","author":"Zimmermann","year":"2007","journal-title":"Drug Discov Today1"},{"key":"10.1016\/j.jare.2025.05.014_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1074348","article-title":"Multi-target regulation of intestinal microbiota by berberine to improve type 2 diabetes mellitus","volume":"13","author":"He","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.jare.2025.05.014_b0110","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1002\/fft2.413","article-title":"The hawthorn (Crataegus pinnatifida Bge.) fruit as a new dietary source of bioactive ingredients with multiple beneficial functions","volume":"5","author":"Ma","year":"2024","journal-title":"Food Front"},{"key":"10.1016\/j.jare.2025.05.014_b0115","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1002\/ptr.7478","article-title":"Hyperoside: a review on its sources, biological activities, and molecular mechanisms","volume":"36","author":"Wang","year":"2022","journal-title":"Phytother Res3"},{"key":"10.1016\/j.jare.2025.05.014_b0120","doi-asserted-by":"crossref","DOI":"10.5246\/jcps.2012.05.063","article-title":"Acute toxicity and genotoxicity evaluation of hyperoside extracted from Abelmoschus manihot (L.) Medic","volume":"21","author":"Ai","year":"2012","journal-title":"J Chin Pharm Sci."},{"key":"10.1016\/j.jare.2025.05.014_b0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jare.2021.06.001","article-title":"Hyperoside attenuates non-alcoholic fatty liver disease in rats via cholesterol metabolism and bile acid metabolism","volume":"34","author":"Wang","year":"2021","journal-title":"J Adv Res"},{"key":"10.1016\/j.jare.2025.05.014_b0130","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4314\/tjpr.v16i2.30","article-title":"Pharmacological activities and pharmacokinetic study of hyperoside: a short review","volume":"16","author":"Raza","year":"2017","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.jare.2025.05.014_b0135","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.jare.2025.05.014_b0140","doi-asserted-by":"crossref","first-page":"4791","DOI":"10.1038\/s41467-019-12896-x","article-title":"Theabrownin from Pu-erh tea attenuates hypercholesterolemia via modulation of gut microbiota and bile acid metabolism","volume":"10","author":"Huang","year":"2019","journal-title":"Nat Commun."},{"key":"10.1016\/j.jare.2025.05.014_b0145","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/jgh.15709","article-title":"Altered bile acid glycine : taurine ratio in the progression of chronic liver disease","volume":"37","author":"Chen","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jare.2025.05.014_b0150","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12016-019-08731-2","article-title":"Comprehensive analysis of serum and fecal bile acid profiles and interaction with gut microbiota in primary biliary cholangitis","volume":"58","author":"Chen","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jare.2025.05.014_b0155","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1124\/dmd.119.089995","article-title":"Flavin-containing monooxygenase 1 catalyzes the production of taurine from hypotaurine","volume":"48","author":"Veeravalli","year":"2020","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.jare.2025.05.014_b0160","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1111\/j.1742-4658.2011.08432.x","article-title":"Cytochrome P450s in the synthesis of cholesterol and bile acids-from mouse models to human diseases","volume":"279","author":"Lorbek","year":"2011","journal-title":"FEBS J"},{"key":"10.1016\/j.jare.2025.05.014_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116567","article-title":"Role of the microbiota-gut-heart axis between bile acids and cardiovascular disease","volume":"174","author":"Zhang","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.jare.2025.05.014_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2025.106011","article-title":"Studying the intracellular bile acid concentration and toxicity in drug-induced cholestasis: comprehensive LC-MS\/MS analysis with human liver slices","volume":"104","author":"Karsten","year":"2025","journal-title":"Toxicol. in Vitro"},{"key":"10.1016\/j.jare.2025.05.014_b0175","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1002\/fft2.482","article-title":"Cyanidin-3-O-glucoside magic: Unveiling the power to inhibit cholesterol absorption via the intestinal farnesoid X receptor-bile acids pathway with Lactobacillus Marvel","volume":"5","author":"Wang","year":"2024","journal-title":"Food Front"},{"key":"10.1016\/j.jare.2025.05.014_b0180","doi-asserted-by":"crossref","first-page":"13592","DOI":"10.3390\/ijms232113592","article-title":"Systemic bile acids affect the severity of acute pancreatitis in mice depending on their hydrophobicity and the disease pathogenesis","volume":"23","author":"Tran","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jare.2025.05.014_b0185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.febslet.2007.11.015","article-title":"FXR signaling in metabolic disease","volume":"582","author":"Zhang","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jare.2025.05.014_b0190","doi-asserted-by":"crossref","first-page":"3050","DOI":"10.1039\/D1FO04085E","article-title":"Protective effects of taurocholic acid on excessive hepatic lipid accumulation via regulation of bile acid metabolism in grouper","volume":"13","author":"Xu","year":"2022","journal-title":"Food Funct"},{"key":"10.1016\/j.jare.2025.05.014_b0195","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.05.014_b0200","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.apsb.2016.07.008","article-title":"Fatty liver diseases, bile acids, and FXR","volume":"6","author":"Zhu","year":"2016","journal-title":"Acta Pharm Sin B."},{"key":"10.1016\/j.jare.2025.05.014_b0205","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J Clin Invest1"},{"key":"10.1016\/j.jare.2025.05.014_b0210","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1017\/S0954422421000081","article-title":"Circulating bile acids as a link between the gut microbiota and cardiovascular health: impact of prebiotics, probiotics and polyphenol-rich foods","volume":"35","author":"Pushpass","year":"2022","journal-title":"Nutr Res Rev"},{"key":"10.1016\/j.jare.2025.05.014_b0215","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1126\/science.284.5418.1362","article-title":"Identification of a nuclear receptor for bile acids","volume":"284","author":"Makishima","year":"1999","journal-title":"Science."},{"key":"10.1016\/j.jare.2025.05.014_b0220","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.jare.2025.05.014_b0225","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab2"},{"key":"10.1016\/j.jare.2025.05.014_b0230","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nm.3760","article-title":"Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance","volume":"21","author":"Fang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/j.jare.2025.05.014_b0235","doi-asserted-by":"crossref","first-page":"216","DOI":"10.15212\/AMM-2024-0082","article-title":"Pathologic and therapeutic insights into cholestatic liver disease-associated depressive disorder","volume":"4","author":"Li","year":"2025","journal-title":"Acta Materia Medica"},{"key":"10.1016\/j.jare.2025.05.014_b0240","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hep.32148","article-title":"Therapeutic targeting of hepatic ACSL4 ameliorates NASH in mice","volume":"75","author":"Duan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2025.05.014_b0245","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jare.2025.05.014_b0250","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jare.2025.05.014_b0255","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.cmet.2022.05.004","article-title":"Inhibition of ATP-citrate lyase improves NASH, liver fibrosis, and dyslipidemia","volume":"34","author":"Morrow","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.05.014_b0260","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.cmet.2020.10.010","article-title":"TANK-binding kinase 1 regulates the localization of acyl-CoA synthetase ACSL1 to control hepatic fatty acid oxidation","volume":"32","author":"Huh","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/j.jare.2025.05.014_b0265","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1152\/ajpendo.00513.2004","article-title":"PPARgamma2 regulates lipogenesis and lipid accumulation in steatotic hepatocytes","volume":"288","author":"Schadinger","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.05.014_b0270","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00535-013-0758-5","article-title":"Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease","volume":"48","author":"Kawano","year":"2013","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.jare.2025.05.014_b0275","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1152\/ajpendo.90958.2008","article-title":"Biochemistry, physiology, and genetics of GPAT, AGPAT, and lipin enzymes in triglyceride synthesis","volume":"296","author":"Takeuchi","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jare.2025.05.014_b0280","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/hep.24708","article-title":"Regulation of hepatic lipin-1 by ethanol: role of AMP-activated protein kinase\/sterol regulatory element-binding protein 1 signaling in mice","volume":"55","author":"Hu","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.jare.2025.05.014_b0285","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1055\/s-0033-1358523","article-title":"Transcriptional control of hepatic lipid metabolism by SREBP and ChREBP","volume":"33","author":"Xu","year":"2013","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jare.2025.05.014_b0290","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1074\/jbc.M610745200","article-title":"Three mammalian lipins act as phosphatidate phosphatases with distinct tissue expression patterns","volume":"282","author":"Donkor","year":"2007","journal-title":"J Biol Chem"}],"container-title":["Journal of Advanced Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322500308X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S209012322500308X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:58:06Z","timestamp":1778835486000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S209012322500308X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":58,"alternative-id":["S209012322500308X"],"URL":"https:\/\/doi.org\/10.1016\/j.jare.2025.05.014","relation":{},"ISSN":["2090-1232"],"issn-type":[{"value":"2090-1232","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperoside modulates bile acid and fatty acid metabolism, presenting a potentially promising treatment for non-alcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Advanced Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jare.2025.05.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of Cairo University.","name":"copyright","label":"Copyright"}]}}